Grufity logoGrufity logo
ScreenerStocksFundsSectorsWatchlists
NUS

Nu Skin Enterprises Inc

NUS

17.53USD+0.34 (+1.98%)Market Closed
Watchlist

Market Summary

USD17.53+0.34
Market Closed
1.98%

NUS Alerts

  • 1 major insider sales recently.
  • Big fall in earnings (Y/Y)
  • Losses in recent quarter

NUS Stock Price

View Fullscreen

NUS RSI Chart

NUS Valuation

Market Cap

875.3M

Price/Earnings (Trailing)

14.96

Price/Sales (Trailing)

0.44

EV/EBITDA

5.71

Price/Free Cashflow

22.97

NUS Price/Sales (Trailing)

NUS Profitability

EBT Margin

2.51%

Return on Equity

8.67%

Return on Assets

4.24%

Free Cashflow Yield

4.35%

NUS Fundamentals

NUS Revenue

Revenue (TTM)

2.0B

Revenue Y/Y

-7.26%

Revenue Q/Q

-0.3%

NUS Earnings

Earnings (TTM)

58.5M

Earnings Y/Y

-45.55%

Earnings Q/Q

-237.42%

Price Action

Last 7 days

4.7%

Last 30 days

1.0%

Last 90 days

-23.6%

Trailing 12 Months

-57.6%

How does NUS drawdown profile look like?

NUS Financial Health

Current Ratio

2.08

NUS Investor Care

Buy Backs (1Y)

0.87%

Diluted EPS (TTM)

1.17

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20232.1B2.0B2.0B0
20222.6B2.5B2.4B2.2B
20212.7B2.8B2.8B2.7B
20202.3B2.3B2.4B2.6B
20192.7B2.6B2.5B2.4B
20182.4B2.6B2.7B2.7B
20172.2B2.2B2.1B2.3B
20162.2B2.2B2.2B2.2B
20152.4B2.4B2.3B2.2B
20143.3B3.3B3.0B2.6B
20132.2B2.3B2.7B3.2B
20121.8B2.0B2.0B2.1B
20111.6B1.6B1.6B1.7B
20101.4B1.4B1.5B1.5B
20091.3B1.3B1.3B1.3B
20080001.2B

Latest Insider Trading transactions for NUS

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Nov 27, 2023
lipman andrew d
sold
-34,220
17.11
-2,000
-
Nov 03, 2023
lipman andrew d
sold
-272,272
17.68
-15,400
-
Oct 25, 2023
lipman andrew d
sold
-38,460
19.23
-2,000
-
Sep 25, 2023
lipman andrew d
sold
-46,040
23.02
-2,000
-
Sep 06, 2023
woodbury edwina d
acquired
626
23.21
27.00
-
Aug 25, 2023
lipman andrew d
sold
-46,660
23.33
-2,000
-
Aug 21, 2023
nathanson laura
sold
-146,360
24.12
-6,068
-
Aug 07, 2023
battle emma s.
sold
-33,262
26.15
-1,272
-
Aug 01, 2023
clark chayce david
sold (taxes)
-6,126
29.74
-206
evp and general counsel
Jul 26, 2023
thomas james d
acquired
-
-
8,328
chief financial officer

1–10 of 50

Which funds bought or sold NUS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Nov 24, 2023
EP Wealth Advisors, LLC
reduced
-86.37
-122,010
215,833
-%
Nov 24, 2023
DEUTSCHE BANK AG\
added
14.87
-179,585
495,105
-%
Nov 22, 2023
Public Sector Pension Investment Board
reduced
-30.29
-1,631,260
1,309,700
0.01%
Nov 22, 2023
KBC Group NV
unchanged
-
-
133,000
-%
Nov 21, 2023
COMERICA BANK
new
-
507,831
507,831
-%
Nov 21, 2023
Walleye Capital LLC
added
70.33
51,330
633,691
-%
Nov 16, 2023
Creative Planning
new
-
406,024
406,024
-%
Nov 15, 2023
JANE STREET GROUP, LLC
added
108
307,619
1,230,410
-%
Nov 15, 2023
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
added
14.51
-19,000
52,000
-%
Nov 15, 2023
GSA CAPITAL PARTNERS LLP
sold off
-100
-679,000
-
-%

1–10 of 45

Latest Funds Activity

Are funds buying NUS calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own NUS
No. of Funds

Schedule 13G FIlings of Nu Skin Enterprises Inc

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Aug 09, 2023
state street corp
6.11%
3,051,276
SC 13G/A
Feb 13, 2023
renaissance technologies llc
4.63%
2,287,596
SC 13G/A
Feb 09, 2023
vanguard group inc
13.13%
6,490,840
SC 13G/A
Feb 09, 2023
state street corp
14.94%
7,384,649
SC 13G/A
Feb 06, 2023
wellington management group llp
7.15%
3,535,969
SC 13G/A
Jan 23, 2023
blackrock inc.
17.0%
8,414,765
SC 13G/A
May 10, 2022
state street corp
17.66%
8,851,823
SC 13G/A
Feb 11, 2022
renaissance technologies llc
5.24%
2,612,396
SC 13G/A
Feb 10, 2022
state street corp
12.61%
6,280,258
SC 13G
Feb 04, 2022
wellington management group llp
8.35%
4,162,517
SC 13G/A

Recent SEC filings of Nu Skin Enterprises Inc

View All Filings
Date Filed Form Type Document
Dec 06, 2023
4
Insider Trading
Nov 28, 2023
4
Insider Trading
Nov 06, 2023
4
Insider Trading
Nov 03, 2023
144
Notice of Insider Sale Intent
Nov 02, 2023
10-Q
Quarterly Report
Nov 01, 2023
8-K
Current Report
Oct 26, 2023
4
Insider Trading
Sep 25, 2023
4
Insider Trading
Sep 25, 2023
144
Notice of Insider Sale Intent
Sep 07, 2023
4
Insider Trading

NUS Fair Value

Loading...

Peers (Alternatives to Nu Skin Enterprises Inc)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
357.9B
83.3B
-2.82% -1.73%
25.07
4.46
3.48% 4.57%
63.2B
19.1B
3.03% 0.36%
35.42
3.52
7.86% -17.69%
50.2B
15.5B
18.36% -43.74%
49.67
3.15
-10.29% -58.06%
22.9B
-
7.67% 16.29%
52.42
75.72
-94.06% -40.65%
17.7B
7.0B
10.49% -3.01%
205.51
2.51
-0.09% -78.77%
MID-CAP
10.3B
5.8B
17.36% 45.41%
26.93
1.77
9.07% 135.16%
6.9B
765.7M
23.42% 128.95%
56.37
8.95
70.85% 258.18%
4.2B
1.3B
2.93% 33.82%
26.53
3.24
31.74% 54.03%
3.4B
8.3B
16.90% -33.44%
-6.19
0.41
-16.40% -201.29%
2.6B
2.0B
9.68% 12.08%
19.05
1.31
-10.15% -19.20%
SMALL-CAP
1.9B
792.6M
41.40% 34.14%
-51.85
2.34
78.34% 58.46%
1.7B
2.3B
-4.73% -17.19%
15.15
0.76
3.68% 14.91%
144.7M
193.7M
21.41% 64.91%
24.17
0.75
-1.01% 0.37%
66.8M
273.5M
16.07% -
-1.44
0.24
-18.31% 56.62%
36.4M
11.0M
7.03% -31.07%
14.42
3.3
-18.80% -16.08%

Nu Skin Enterprises Inc News

Latest updates
MarketWatch05 Dec 202309:33 pm37 hours ago
Defense World05 Dec 202308:46 am2 days ago
Defense World01 Dec 202310:19 am6 days ago
Marketscreener.com29 Nov 202309:16 pm7 days ago
GuruFocus.com27 Nov 202303:05 pm9 days ago
GuruFocus.com22 Nov 202308:00 am15 days ago
Yahoo Finance17 Nov 202308:00 am20 days ago
Yahoo Finance06 Nov 202308:00 am31 days ago
MarketWatch06 Nov 202308:00 am31 days ago
Yahoo Finance02 Nov 202307:00 am35 days ago
Yahoo Finance30 Oct 202307:00 am38 days ago
Nasdaq30 Oct 202307:00 am38 days ago
Seeking Alpha17 Oct 202307:00 am51 days ago
Yahoo Finance10 Oct 202307:00 am58 days ago

Financials for Nu Skin Enterprises Inc

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue-0.3%499500481522538561605673641704677748703612518583590624624683675
Gross Profit-19.9%292365348375364413443500482532506553520458392443450469477521518
Operating Expenses-1.1%319322332347385361391479417447444465446400356388380395408503437
  S&GA Expenses1.4%188185188201216219243263260281276295281249206228232246250269272
EBITDA Margin---0.06*0.07*0.07*5.02*0.11*0.11*0.14*0.14*0.14*0.14*0.13*0.13*0.14*0.15*-----
Income Taxes-75.5%3.0010.003.00-32.86-3.579.0012.0028.0018.0022.0017.0018.0018.0018.0011.0013.0021.0025.0023.0032.0021.00
Earnings Before Taxes-192.8%-34.4537.0015.0024.00-28.9643.0051.0018.0068.0081.0064.0091.0075.0060.0030.0054.0065.0071.0066.0014.0074.00
EBT Margin---0.03*0.04*0.03*3.56*0.08*0.09*0.11*0.11*0.11*0.10*0.09*0.09*0.09*0.11*-----
Net Income-237.4%-36.9527.0011.0057.00-25.3934.0039.00-9.2350.0059.0047.0073.0056.0042.0020.0040.0044.0046.0043.00-17.7653.00
Net Income Margin---0.04*0.05*0.02*2.24*0.05*0.05*0.08*0.08*0.08*0.07*0.07*0.06*0.06*0.07*-----
Free Cashflow----33.5612.003.0037.00-2.7491.0017.003.00-38.2380.0098.0088.0050.0037.00-----
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets-5.3%1,7931,8941,8251,8211,7631,9011,8921,9061,9742,0501,9501,9571,8171,7941,7461,7691,7371,7911,7551,6941,746
  Current Assets-11.5%701793774760778883849873891962901903772786730740739788748799826
    Cash Equivalents-1.0%233236230265294364302340282355339403367376353336320361310387390
  Inventory-21.8%291372367346327354382400415391363314270262257276283293304296289
  Net PPE-0.3%429430438445433443449454464474464468456445449454448443446465497
  Goodwill0%229229206206206206206206216216203203197197197197197197197197187
Liabilities-2.8%9719989329249219609589941,0381,1321,0791,0639891,002946894891956944913914
  Current Liabilities-2.5%434445373359366384494530541616562543466485420357368415402440428
    LT Debt, Current0%14014048.0025.0043.0040.0011010811015390.0030.0030.0095.0095.0028.0025.0060.0045.0069.0082.00
    LT Debt, Non Current-1.3%363368373377382387259269279288298305313320327334342349356361366
Shareholder's Equity-8.2%822895893897842941934913936918871894827792800875846835811782832
  Retained Earnings-2.9%1,8821,9391,9311,9391,9011,9461,9311,9121,9401,9091,8691,8411,7861,7491,7271,7281,7081,6851,6591,6361,675
  Additional Paid-In Capital0.6%619616611613610606599602591587579580570563558558557556553553545
Shares Outstanding-100.0%-50.0050.00-50.0050.0050.00-50.0050.0051.00-51.0052.0055.00-56.0056.0055.00-56.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations43.6%51,02735,522-22,07725,52528,44146,5557,541109,50930,21420,715-18,85694,693118,36797,05469,02749,90353,55182,663-8,18688,88861,917
  Share Based Compensation-22.4%3,7254,8014,0023,0473,1712,0224,1276,7183,0936,5806,8038,6217,1154,8693,4552601,0153,5935,0416,2987,044
Cashflow From Investing87.1%-11,906-92,501-14,696-13,385-25,211-18,350-10,133-15,577-17,914-36,439-18,796-29,489-21,450-9,305-19,184-13,283-23,683-16,304-18,142-33,523-16,990
Cashflow From Financing-156.4%-38,37467,9891,380-50,794-61,10946,158-33,759-35,916-80,01929,388-18,155-41,839-110,794-69,554-22,979-25,552-62,570-13,705-52,967-57,904-49,825
  Dividend Payments0.1%19,48619,47519,39219,02719,30319,39219,29318,93619,00719,04019,28919,10019,24519,35620,68620,55320,55220,55320,53120,18620,304
  Buy Backs-13,011--10,00740,02810,00410,00610,00510,00510,00450,40616,97319,99446,48160,886---82521,34312,399

NUS Income Statement

2023-06-30
Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Consolidated Statements of Income [Abstract]    
Revenue$ 500,257$ 560,615$ 981,719$ 1,165,514
Cost of sales135,542148,100269,130309,599
Gross profit364,715412,515712,589855,915
Operating expenses:    
Selling expenses185,165219,426373,289462,125
General and administrative expenses137,044141,562270,943290,118
Restructuring and impairment expenses009,7870
Total operating expenses322,209360,988654,019752,243
Operating income42,50651,52758,570103,672
Other expense, net(5,393)(8,640)(6,869)(10,093)
Income before provision for income taxes37,11342,88751,70193,579
Provision for income taxes10,2218,65013,43320,626
Net income$ 26,892$ 34,237$ 38,268$ 72,953
Net income per share (Note 6):    
Basic (in dollars per share)$ 0.54$ 0.68$ 0.77$ 1.45
Diluted (in dollars per share)$ 0.54$ 0.67$ 0.76$ 1.43
Weighted-average common shares outstanding:    
Basic (in shares)49,93150,36849,78950,181
Diluted (in shares)50,16150,96050,09850,959

NUS Balance Sheet

2023-06-30
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 235,554$ 264,725
Current investments16,77213,784
Accounts receivable, net67,16647,360
Inventories, net372,250346,183
Prepaid expenses and other100,83387,816
Total current assets792,575759,868
Property and equipment, net430,328444,806
Operating lease right-of-use assets94,70798,734
Goodwill229,469206,432
Other intangible assets, net112,61966,701
Other assets234,078244,429
Total assets1,893,7761,820,970
Current liabilities:  
Accounts payable49,52953,963
Accrued expenses255,510280,280
Current portion of long-term debt140,00025,000
Total current liabilities445,039359,243
Operating lease liabilities74,48776,540
Long-term debt367,753377,466
Other liabilities111,152110,425
Total liabilities998,431923,674
Commitments and contingencies (Notes 5 and 11)
Stockholders' equity:  
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued9191
Additional paid-in capital615,579613,278
Treasury stock, at cost - 40.6 million and 41.1 million shares(1,557,777)(1,569,061)
Accumulated other comprehensive loss(101,446)(86,509)
Retained earnings1,938,8981,939,497
Total stockholders' equity895,345897,296
Total liabilities and stockholders' equity$ 1,893,776$ 1,820,970
NUS
Nu Skin Enterprises, Inc., together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products. The company also provides wellness products, such as ageLOC Meta, LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
 CEO
 WEBSITEwww.nuskin.com
 EMPLOYEES3800

Nu Skin Enterprises Inc Frequently Asked Questions


What is the ticker symbol for Nu Skin Enterprises Inc? What does NUS stand for in stocks?

NUS is the stock ticker symbol of Nu Skin Enterprises Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Nu Skin Enterprises Inc (NUS)?

As of Wed Dec 06 2023, market cap of Nu Skin Enterprises Inc is 875.29 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NUS stock?

You can check NUS's fair value in chart. The fair value of Nu Skin Enterprises Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Nu Skin Enterprises Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NUS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Nu Skin Enterprises Inc a good stock to buy?

The fair value guage provides a quick view whether NUS is over valued or under valued. Whether Nu Skin Enterprises Inc is cheap or expensive depends on the assumptions which impact Nu Skin Enterprises Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NUS.

What is Nu Skin Enterprises Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 06 2023, NUS's PE ratio (Price to Earnings) is 14.96 and Price to Sales (PS) ratio is 0.44. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NUS PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Nu Skin Enterprises Inc's stock?

In the past 10 years, Nu Skin Enterprises Inc has provided -0.16 (multiply by 100 for percentage) rate of return.